The Guardian
Email YouTube Facebook Instagram Twitter WhatsApp

Nigerian firm gets approval to produce Chlorxy-G Gel

Related

Efforts at driving down mortality rate in the country and the West Africa sub-region may have paid up as a Nigerian pharmaceutical firm, Drugfield Pharmaceuticals Limited has received the West Africa Health Organisation (WAHO) approval for its product Chlorxy-G (7.1%) gel, a brand of Chlorhexidine Digluconate, which is a broad spectrum antiseptic that is available in a range of concentrations for umbilical cord care.

This certification would enable the distribution and sale the drug in 15 ECOWAS countries. Over 25 countries across the globe are already implementing the use of Chlorxy-G for umbilical cord care.

Commenting, Chief Executive Officer of the company, Olakunle Ekundayo, who made this known during a media briefing, said the product is a new treatment approach approved by WHO for umbilical cord of newborn babies.

He went on to call on the Federal Government to boost local manufacturing of drugs by restricting importation of competing finished products, granting drug manufacturers greater access to foreign exchange and zero import duty on imported inputs for local manufacturing of drugs such as Active Pharmaceutical Ingredients (APIs), excipients, primary packaging materials and equipment.


In this article:
Chlorxy-G GelWAHO
Receive News Alerts on Whatsapp: +2348136370421

No comments yet